Tachyon Ventures is invests in early-stage life sciences ventures at the forefront of medicine, biotech and bioengineering.
Tachyon Ventures invests in early-stage life sciences ventures at the forefront of medicine, biotech, and bioengineering. They seek scientific teams pursuing ambitious goals, backed by world-leading research (and secured IP) in the fields of immunotherapy, gene therapy / genetic engineering, organ engineering, and stem cell / regenerative medicine.
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Sep 9, 2021
Mammoth Biosciences
|
Series D | $150M | Biotechnology | — |
Jan 30, 2020
Mammoth Biosciences
|
Series B | $45M | Biotechnology | — |
Jul 31, 2018
Mammoth Biosciences
|
Series A | $23M | Biotechnology | — |